Executive Overview In the relentless global pursuit of a viable therapeutic weapon against Alzheimer’s disease, a team of molecular pharmacologists...
Carried by millions worldwide, the APOE4 gene variant stands as the single most potent known genetic risk factor for late-onset...
Executive Overview For decades, the mainstream neuroscientific consensus framed Alzheimer’s disease primarily through the lens of protein aggregation—specifically, the extracellular...
Executive Overview Imagine a minor kitchen fire breaking out in a single, isolated corner of your home. With a targeted...
Executive Overview In a monumental leap forward for precision medicine and neurodegenerative research, scientists at Johns Hopkins Medicine have unveiled...
